Psychosocial Impact of the Bionic Pancreas During Summer Camp
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background: The psychosocial impact of the bionic pancreas (BP) was assessed among children attending diabetes camp. Methods: Nineteen children were randomly assigned for 5 days to the BP condition and 5 days to the control condition in a crossover design. Results: Significant reductions in hypoglycemic fear and regimen burden were found. Children felt less burdened or worried about diabetes and felt freer to do things they enjoyed while using the BP. Children wished the BP responded to out of range numbers faster and expressed annoyance about carrying around the necessary equipment. Conclusions: Children may experience improved psychosocial outcomes following use of BP while expressing key areas of user concern. Future studies in less controlled environments with larger sample sizes can determine if these findings are generalizable to other groups.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These systems may also lower the risk of exercise-related hypoglycemia (219) and have been shown to have psychosocial benefits (221)(222)(223)(224)(225).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [221]
Citations
Cites
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Artificial Pancreas: Past, Present, Future
Cobelli, C., Renard, E., & Kovatchev, B. (2011) · Diabetes · doi:10.2337/db11-0654 · Cited by 600
Weinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Phillip, M., Battelino, T., Atlas, E., Kordonouri, O., Bratina, N., Miller, S., Biester, T., Avbelj Stefanija, M., Muller, I., Nimri, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206881 · Cited by 435
A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
El-Khatib, F. H., Russell, S. J., Nathan, D. M., Sutherlin, R. G., & Damiano, E. R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000619 · Cited by 403
Fully Integrated Artificial Pancreas in Type 1 Diabetes
Breton, M., Farret, A., Bruttomesso, D., Anderson, S., Magni, L., Patek, S., Dalla Man, C., Place, J., Demartini, S., Del Favero, S., et al. (2012) · Diabetes · doi:10.2337/db11-1445 · Cited by 315
MD-Logic Artificial Pancreas System
Atlas, E., Nimri, R., Miller, S., Grunberg, E. A., & Phillip, M. (2010) · Diabetes Care · doi:10.2337/dc09-1830 · Cited by 266
Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
Castle, J. R., Engle, J. M., Youssef, J. E., Massoud, R. G., Yuen, K. C. J., Kagan, R., & Ward, W. K. (2010) · Diabetes Care · doi:10.2337/dc09-2254 · Cited by 232
Haidar, A., Legault, L., Messier, V., Mitre, T. M., Leroux, C., & Rabasa-Lhoret, R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70226-8 · Cited by 214
Research works printed but not linked: 4
- El-Khatib F, 2010, Sci Transl Med, 4, 1374
- Russell S, 2016, Lancet Diabetes Endocrinol
- Weissberg-Benchell J, Abstract presented at: 75th Scientific Sessions, American Diabetes Association
- Weissberg-Benchell J, Abstract published from: 75th Annual Scientific Sessions, American Diabetes Association
Cited by
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 250
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
Breton, M. D., Cherñavvsky, D. R., Forlenza, G. P., DeBoer, M. D., Robic, J., Wadwa, R. P., Messer, L. H., Kovatchev, B. P., & Maahs, D. M. (2017) · Diabetes Care · doi:10.2337/dc17-0883 · Cited by 179
“The use of CLC systems hasdecreasedhypoglycemia fearandburden among children attending summer camp (23).”
Background7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 280
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
Pinsker, J. E., Müller, L., Constantin, A., Leas, S., Manning, M., McElwee Malloy, M., Singh, H., & Habif, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0388 · Cited by 147
“The overall score for the TAS (used at T1 only) was 49.7 ( – 15.3) (score range = - 80 to + 80), demonstrating participants’ endorsement and acceptance of Control-IQ technology (Table 4).”
InfluentialBerget, C., Messer, L. H., Vigers, T., Frohnert, B. I., Pyle, L., Wadwa, R. P., Driscoll, K. A., & Forlenza, G. P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.12962 · Cited by 138
Psychosocial impacts of hybrid closed‐loop systems in the management of diabetes: a review
Farrington, C. (2018) · Diabetic Medicine · doi:10.1111/dme.13567 · Cited by 121
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Weissberg-Benchell, J. A., Shapiro, J. B., Hood, K. K., Laffel, L. M., Naranjo, D. M., Miller, K. M., & Barnard, K. D. (2019) · Diabetic Medicine · doi:10.1111/dme.13930 · Cited by 100
Self-citationBisio, A., Gonder-Frederick, L., McFadden, R., Cherñavvsky, D., Voelmle, M., Pajewski, M., Yu, P., Bonner, H., & Brown, S. A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820986879 · Cited by 76
Kudva, Y. C., Laffel, L. M., Brown, S. A., Raghinaru, D., Pinsker, J. E., Ekhlaspour, L., Levy, C. J., Messer, L. H., Kovatchev, B. P., Lum, J. W., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0089 · Cited by 68
Bisio, A., Brown, S. A., McFadden, R., Pajewski, M., Yu, P. L., DeBoer, M., Schoelwer, M. J., Bonner, H. G., Wakeman, C. A., Cherñavvsky, D. R., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13164 · Cited by 57
“This 37 item questionnaire, rated on a 5 point Likert scale, has been used in previous AID research (bionic pancreas) and was adapted for this study.(27) It yields to two subscales scores (Burdens and Benefits) with higher scores in each subscale”
MethodRoos, T., Hermanns, N., Groß, C., Kulzer, B., Haak, T., & Ehrmann, D. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102852 · Cited by 62
“For fear of hypoglycaemia, mainly one study showed an impact on the SMD. 44 Regarding quality of life only three studies for adults and fi ve for paediatrics/adolescents were found, therefore, sensitivity analyses emphasized this limitation.”
BackgroundMethodInfluentialFranceschi, R., Mozzillo, E., Candia, F. D., Maines, E., Leonardi, L., Girardi, M., Fedi, L., Rosanio, F. M., & Marcovecchio, M. L. (2023) · Diabetic Medicine · doi:10.1111/dme.15099 · Cited by 48
O'Donnell, S., Lewis, D., Marchante Fernández, M., Wäldchen, M., Cleal, B., Skinner, T., Raile, K., Tappe, A., Ubben, T., Willaing, I., et al. (2019) · JMIR Research Protocols · doi:10.2196/15368 · Cited by 38
“Qualitative research on commercially developed closed-loop systems has indicated that individuals using these systems for relatively short periods report reduced anxiety [10-14], improved quality of sleep [10,14-17], and reduced burden of managing diabetes [12,13,17-19] and this led to greater freedom and flexibility…”
BackgroundResultPriesterroth, L., Grammes, J., Clauter, M., & Kubiak, T. (2021) · Diabetic Medicine · doi:10.1111/dme.14581 · Cited by 43
Bisio, A., Anderson, S. M., Norlander, L., O’Malley, G., Robic, J., OGYAADU, S. J., Hsu, L. J., Levister, C. M., Ekhlaspour, L., Lam, D. W.-H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0838 · Cited by 40
Troncone, A., Bonfanti, R., Iafusco, D., Rabbone, I., Sabbion, A., Schiaffini, R., Galderisi, A., Marigliano, M., Rapini, N., Rigamonti, A., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1073 · Cited by 33
“The two existing studies (10,11) assessing the impact of an AP system on children under real-life conditions described reductions in worries about hypoglycemia and regimen burden, a high level of satisfaction, and an increased perceived ease of use of the new technology.”
BackgroundWeissberg-Benchell, J. A., Vesco, A. T., Shapiro, J. B., Calhoun, P. M., Damiano, E. R., Russell, S. J., Li, Z., El-Khatib, F. H., Ruedy, K. J., BALLIRO, C. A., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0238 · Cited by 31
“, 11, 13 Finally, our data suggest that adults with more negative attitudes toward diabetes technologies (lower DSAT), children whose caregivers reported higher levels of diabetes-specific emotional distress (high DDS), and children with worse perceived well-being (lower WHO-5) at baseline showed a…”
Self-citationAdvances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes
Dadlani, V., Pinsker, J. E., Dassau, E., & Kudva, Y. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1051-z · Cited by 32
Colmegna, P. H., Bisio, A., McFadden, R. K., WAKEMAN, C. A., Oliveri, M. C., Nass, R. M., & Breton, M. D. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3209090 · Cited by 34
“acceptance (TA) questionnaire based on [26].”
Elian, V., Popovici, V., Ozon, E.-A., Musuc, A. M., Fița, A. C., Rusu, E., Radulian, G., & Lupuliasa, D. (2023) · Life · doi:10.3390/life13081663 · Cited by 41
Psychosocial Aspects of Diabetes Technology Use
Papadakis, J. L., Anderson, L. M., Garza, K. P., Feldman, M. A., Shapiro, J. B., Evans, M. A., Thompson, L. G., & Weissberg-Benchell, J. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.004 · Cited by 30
Self-citationForlenza, G. P., Raghinaru, D., Cameron, F. M., Bequette, B. W., Chase, H. P., Wadwa, R. P., Maahs, D. M., Jost, E., Ly, T. T., Wilson, D. M., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12603 · Cited by 28
Gu, J., Chaput, K. H., Dunlop, A. D., Booth, J. E., Feig, D. S., & Donovan, L. (2023) · Diabetic Medicine · doi:10.1111/dme.15044 · Cited by 19
Deshpande, S., Pinsker, J. E., Church, M. M., Piper, M. M., ANDRE, C. C., MASSA, J. S., Doyle, F. J., Eisenberg, D. M., & Dassau, E. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0022 · Cited by 18
“The Technology Acceptance Questionnaire, given at the end of the 2 weeks of iAPS use, was used to assess acceptance and ease of use of the system, with a score of 1 (strongly disagree) to 5 (strongly agree) for each question.(31) The System Usability Scale (SUS) assessed overall usability.”
MethodOukes, T., Blauw, H., van Bon, A. C., DeVries, J. H., & von Raesfeld, A. M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818823728 · Cited by 15
Barnard-Kelly, K. D., Gonder-Frederick, L. A., Weissberg-Benchell, J. A., & Wisk, L. E. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241276550 · Cited by 12
“30-33,35, 36 Assessing the psychosocial impact of diabetes technology is necessary as the success of these technologies is predicated upon whether the user finds more benefits than burdens 20,27 and is therefore willing to not only try the device, but also continue using it.”
Self-citationAng, K. H., & Sherr, J. L. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1360862 · Cited by 11
Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas
Howard, K. R., Garza, K. P., Feldman, M. A., & Weissberg-Benchell, J. A. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsae022 · Cited by 10
Self-citationSperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Marigliano, M., Mozzillo, E., Mancioppi, V., Candia, F. D., Rosanio, F. M., Antonelli, A., Nichelatti, I., Maffeis, C., Tumini, S., & Franceschi, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071031 · Cited by 10
Human Factor Considerations for Artificial Pancreas Research
Gonder-Frederick, L. A., Grabman, J. H., & Shepard, J. A. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0403 · Cited by 9
Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements
Giménez, M., Conget, I., & Oliver, N. S. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211029937 · Cited by 8
Beato-Víbora, P. I., Lázaro-Martín, L., Gallego-Gamero, F., & Ambrojo-López, A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821993170 · Cited by 5
Shapiro, J. B., Vesco, A. T., Carroll, M. S., & Weissberg-Benchell, J. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0117 · Cited by 3
Self-citationHybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes
Service, C. H. T. A. (2021) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2021.50 · Cited by 4
Diabetes Without Math as Automation Advances: A Shifting Clinical Paradigm
Mora, P. A., Cook, K. P., & MacLeod, J. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2025.0033 · Cited by 3
“56,57 Diabetes-related distress scales are available for assessing diabetes distress in T1D and T2D.”
Papa, G. F. S., Cannarella, R., Finocchiaro, C., Anzaldi, M., Gruttadauria, G., Presti, D. L., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.108984 · Cited by 2
Zucchini, S. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00676-5
Metadata
- Authors
- Weissberg-Benchell, J., Hessler, D., Polonsky, W. H., & Fisher, L.
- Affiliations
- Northwestern University (US)
- University of California, San Francisco (US)
- Behavioral Diabetes Institute, Del Mar, CA, USA
- Corresponding author
- Weissberg-Benchell, Jill
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2016-03-17
- Volume
- 10
- Issue
- 4
- Pages
- 840-844
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC4928236
- OpenAlex
- W2305146281
- Cited by
- 47
- References
- 23
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 10 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 2
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- bionic pancreas, diabetes camp, pediatric diabetes, psychosocial impact, artificial pancreas, user concerns
- MeSH terms
- Child, Diabetes Mellitus, Type 1, Female, Humans, Male, Cross-Over Studies, Pancreas, Artificial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.